EUR 2.85
(-2.9%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 172.73 Million CAD | 10.66% |
2022 | 121.06 Million CAD | 55.54% |
2021 | 77.83 Million CAD | 164.39% |
2020 | 29.43 Million CAD | -4.62% |
2019 | 30.86 Million CAD | 360.44% |
2018 | 6.7 Million CAD | 85.69% |
2017 | 3.61 Million CAD | 35.64% |
2016 | 2.66 Million CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 30.96 Million CAD | 0.65% |
2024 Q2 | 32.19 Million CAD | 0.46% |
2024 Q1 | 32.04 Million CAD | -52.02% |
2023 Q3 | 34.7 Million CAD | 4.86% |
2023 Q2 | 33.09 Million CAD | -5.82% |
2023 Q1 | 35.13 Million CAD | 3.93% |
2023 FY | 133.97 Million CAD | 10.66% |
2023 Q4 | 66.79 Million CAD | 92.46% |
2022 Q3 | 29.67 Million CAD | 0.89% |
2022 Q1 | 28.16 Million CAD | 52.68% |
2022 Q4 | 33.8 Million CAD | 13.92% |
2022 FY | 121.06 Million CAD | 55.54% |
2022 Q2 | 29.41 Million CAD | 4.44% |
2021 Q1 | 16.61 Million CAD | 92.31% |
2021 Q3 | 23.52 Million CAD | 22.22% |
2021 Q4 | 18.44 Million CAD | -21.59% |
2021 Q2 | 19.24 Million CAD | 15.87% |
2021 FY | 77.83 Million CAD | 164.39% |
2020 FY | 29.43 Million CAD | -4.62% |
2020 Q2 | 7.25 Million CAD | 10.35% |
2020 Q4 | 8.63 Million CAD | 23.97% |
2020 Q1 | 6.57 Million CAD | -38.61% |
2020 Q3 | 6.96 Million CAD | -4.0% |
2019 Q3 | 7 Million CAD | 2.07% |
2019 FY | 30.86 Million CAD | 360.44% |
2019 Q4 | 10.71 Million CAD | 53.04% |
2019 Q2 | 6.85 Million CAD | 2.9% |
2019 Q1 | 6.66 Million CAD | 170.24% |
2018 Q3 | 1.82 Million CAD | 19.61% |
2018 Q2 | 1.52 Million CAD | 56.74% |
2018 FY | 6.7 Million CAD | 85.69% |
2018 Q4 | 2.46 Million CAD | 35.23% |
2018 Q1 | 972.95 Thousand CAD | -25.73% |
2017 Q3 | 975.94 Thousand CAD | 0.0% |
2017 Q4 | 1.31 Million CAD | 34.23% |
2017 FY | 3.61 Million CAD | 35.64% |
2016 FY | 2.66 Million CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Newron Pharmaceuticals S.p.A. | 21.41 Million EUR | -706.559% |
Redcare Pharmacy NV | 399.83 Million EUR | 56.797% |